InsiderTrades

Form 4 for SLDB Solid Biosciences Inc.

Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-03 · accession 0000950170-24-002599 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2024-01-05 2024-01-03 SLDB Ganot Ilan Dir M - OptEx — +2,993 9,309 +47% —
DI 2024-01-05 2024-01-03 SLDB Ganot Ilan Dir S - Sale+OE $5.30 -1,142 8,167 -12% -$6,053
DI 2024-01-05 2024-01-03 SLDB Ganot Ilan Dir M - OptEx $0.00 -2,993 8,982 -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-03 M A 2,993 — 9,309 I Wife — — (F1) Restricted stock units convert to common stock on a one-for-one basis.
2 Common Common Stock 2024-01-03 S D 1,142 $5.30 8,167 I Wife — — (F2) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Ms. Ganot.
3 Derivative Restricted Stock Units 2024-01-03 M D 2,993 $0.00 8,982 I Wife — · — to — 2,993 Common Stock (F1) Restricted stock units convert to common stock on a one-for-one basis. (F5) On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.